During Market hours on Monday – 02.05.2022

  • The Dow (Symbol: DIA) went up 0.32%. The S&P 500 (Symbol: SPY) gained 0.60%. and the Nasdaq (Symbol: QQQ) rose 1.67%.
  • Moderna (Symbol: MRNA) — Shares of Moderna jumped 5.7% after the company said its Covid-19 vaccine for children under 6 years old will be ready for review in June by a Food and Drug Administration panel. Moderna applied for emergency use authorization for the treatment last week.
  • Moody’s Corp (Symbol: MCO) — The risk assessment firm dropped 4.9% after the company cut its full-year earnings guidance. The company now expects full-year earnings to range between $10.75 and $11.25 per share excluding items. Previous guidance projected between $12.40 and $12.90 per share. Analysts estimated $11.92, according to FactSet.
  • Johnson Controls (Symbol: JCI) — Shares rose 2.8% after Bank of America initiated coverage of the HVAC producer with a buy rating. Johnson Controls International has 42% upside from here because of the trend toward decarbonization, specifically in the construction of smart buildings, according to Bank of America.
  • Activision Blizzard (Symbol: ATVI) — Shares of Activision Blizzard rose 3.3% after Warren Buffett said Berkshire Hathaway has been upping its stake in the video game publisher and owns about 9.5% as it bets that Microsoft will close its proposed acquisition of the company.
  • Amazon (Symbol: AMZN) — Amazon lost 3% before turning slightly positive, following sharp losses from last week, when it reported a big net loss for the most-recent quarter and a issued bleak financial forecast. Wedbush Securities also removed the stock from its Best Ideas list.

During Premarket hours today (Tuesday – 03.05.2022):

  • Paramount Global (Symbol: PARA) — Paramount Global fell 4.3% in the premarket, despite quarterly profit that beat Wall Street estimates. Revenue came in below analysts’ forecasts for the media company, amid increasing video streaming competition and weak ad sales growth.
  • Hilton Worldwide (Symbol: HLT) — The hotel operator beat estimates by 6 cents a share, with quarterly earnings of 71 cents per share, helped by a rebound in travel demand. Hilton also issued a lower-than-expected full-year outlook.
  • Biogen (Symbol: BIIB) — The drugmaker earned $3.62 per share for its latest quarter, short of the $4.38 a share consensus estimate. Revenue was slightly above forecasts. Results were hurt by cheaper competition for its multiple sclerosis drug Tecfidera. Biogen also announced that CEO Michel Vounatsos will step down, and its shares fell 2.6% in the premarket.
  • Pfizer (Symbol: PFE) — Pfizer reported a first-quarter profit of $1.62 per share, 15 cents a share above estimates. Revenue topped forecasts as well. The drugmaker cut its full-year outlook due to an accounting change. Pfizer shares fell 1.3% in premarket action.
  • Expedia (Symbol: EXPE) — Expedia lost 47 cents per share for its latest quarter, but that was less than the 62 cents a share loss that analysts had anticipated for the travel services company. Revenue exceeded estimates, as travel demand remained strong despite concerns about Covid, Ukraine and other factors. Expedia shares gained 1.5% in the premarket.
  • Avis Budget (Symbol: CAR) — The car rental company’s stock surged 6.8% in the premarket after it reported a much better than expected quarterly profit and also announced a $3 billion increase in its share repurchase authorization.

*Any information contained in this article, including any information contained in external third party links, if any, is solely for informational purposes and does not contain, or should not be construed as containing, investment advice or an investment recommendation, or, an offer of or solicitation for any transactions in financial instruments. Past performance does not guarantee or predict future performance. Colmex Pro Ltd does not take into account your personal investment objectives or financial situation and makes no representation, and assumes no liability to the accuracy or completeness of the information provided, nor for any loss arising from any investment based on presented information.